SEC Comment Letter for CEL SCI CORP (CVM) (CIK 0000725363) (CVM) — Apr 19, 2017

CEL SCI CORP (CVM) (CIK 0000725363)
Date: April 19, 2017 · CIK: 0000725363 · Accession: 0000000000-17-013499

View on Edgar

AI Filing Summary & Sentiment

Sentiment

Urgency

Document Type

Confidence

SEC Posture

Company Posture

Summary

Reasoning

Date

April 19, 2017

Author

Geert Kersten

Form

UPLOAD

Company

CEL SCI CORP (CVM) (CIK 0000725363)

Letter

April 19, 2017 Geert Kersten Chief Executive Officer Cel-Sci Corporation 8229 Boone Blvd. Suite 802 Vienna, Virginia 22182 Cel-Sci Corporation Preliminary Proxy Statement on Schedule 14A Filed March 17, 2017 File No. 001-11889Re: Dear Mr. Kersten: We have completed our review of your filing. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence by the staff. Division of Corporation Finance Office of Healthcare & Insurance

Show Raw Text

April 19, 2017
Geert Kersten
Chief Executive Officer
Cel-Sci Corporation
8229 Boone Blvd.
Suite 802
Vienna, Virginia 22182
Cel-Sci Corporation
Preliminary Proxy Statement on Schedule 14A
Filed March 17, 2017
File No. 001-11889Re:
Dear Mr. Kersten:
        We have completed our review of your filing.  We remind you that the company and its
management are responsible for the accuracy and adequacy of their disclosures, notwithstanding
any review, comments, action or absence by the staff.
Division of Corporation Finance
Office of Healthcare & Insurance

SecProbe.io